Hot Investor Mandate 1: Corporation Invests in Diagnostics and Research Tools in Oncology, Hemotology, Pain and Cardiology

22 Sep

A laboratory science and services company makes venture investments in early stage companies that could enrich the firm’s future pipelines, as well as connect with more mature companies that may be targets for M&A. For venture rounds, the firm co-invests with other venture firms and will typically contribute in the range of $2-5 M for Series A, and $5-6 M for Series B and/or C. Overall, the firm will contribute $10-15 M throughout the lifetime of the investment. The firm typically makes around 2 investments per year.

The firm looks for opportunities related to research tools, diagnostics, centralized labs, and CROs that address the areas of toxicology, forensics, food and supplement testing, biopharmaceutical services, and molecular diagnostics. Some particular indications of interest are hematology, oncology, pain management, cardiology, and behavioral health. The firm is also interested in opportunities related to animal health.

The firm looks for an established management team and defined strategic plan for their raised capital. For venture investments, there should be pre-clinical data or prototypes available. If the company is a university spin-out, there should be some data acquired outside the academic setting already.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: